44th week of 2010 patent applcation highlights part 50 |
Patent application number | Title | Published |
20100280246 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE - Novel linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye are provided. These linkers facilitate the efficient transfer of energy between a donor and acceptor dye in an energy transfer dye. One of these linkers for linking a donor dye to an acceptor dye in an energy transfer fluorescent dye has the general structure R | 2010-11-04 |
20100280247 | PROCESS IMPROVEMENT USING TMEDA - An improved chemical synthesis for compounds having useful biological activity is disclosed, where the use of TMEDA or N,N,N′,N′-tetramethyl-ethane-1,2-diamine gives improved yield. | 2010-11-04 |
20100280248 | NOVEL COMPOUNDS THAT ARE USEFUL FOR IMPROVING PHARMACOKINETICS - Novel compounds of formula 1 | 2010-11-04 |
20100280249 | SYNTHESIS OF 4-AMINO-THALIDOMIDE ENANTIOMERS - The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds. | 2010-11-04 |
20100280250 | THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS - A compound comprising a prodrug of a prostaglandin EP | 2010-11-04 |
20100280251 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES - Disclosed is a method for preparing a compound of Formula 1 comprising contacting a compound of Formula 2 with a metal cyanide reagent, a copper(I) salt reagent, an iodide salt reagent and at least one compound of Formula 3 | 2010-11-04 |
20100280252 | POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS - The present invention provides bifunctional polymers, methods of preparing the same, and intermediates thereto. These compounds are useful in a variety of applications including the PEGylation of biologically active molecules. The invention also provides methods of using said compounds and compositions thereof. | 2010-11-04 |
20100280253 | PRODUCTION METHOD OF 6-HALOGENO-3-ARYLPYRIDINE DERIVATIVE - [Problem] The present invention provides an industrially advantageous production method of a 6-halogeno-3-arylpyridine derivative in which cryogenic condition is not required, production step is short, and an isomer difficult to be separated is not produced as a by-product, | 2010-11-04 |
20100280254 | PREPARATION OF A LEAD-FREE PRIMARY EXPLOSIVE - Embodiments of the present subject matter provide a compound and material that may be used as a lead-free primary explosive. An embodiment of the present subject matter provides the compound copper(I) nitrotetrazolate. Certain embodiments of the present subject matter provide methods for preparing lead-free primary explosives. The method includes: providing a cupric salt; providing water; providing a 5-nitrotetrazolate salt; combining the cupric salt, water and 5-nitrotetrazolate salt to form a mixture, heating the mixture, adding a reducing agent and stirring with continued heating. The method may also include providing cupric chloride, sodium 5-nitrotetrazolate and sodium ascorbate. Certain embodiments of the present subject matter also provide methods for preparing copper(I) nitrotetrazolate. The method includes: providing cupric salt; providing water; providing 5-nitrotetrazolate salt; combining the cupric salt, water and 5-nitrotetrazolate salt to form a mixture, heating the mixture, adding a reducing agent and stirring with continued heating. The method may also include providing cupric chloride, sodium 5-nitrotetrazolate and sodium ascorbate. | 2010-11-04 |
20100280255 | PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES - The present invention relates to methods of making compounds that inhibit 11-hydroxysteroid dehydrogenase type 1 enzyme (11-HSD1). One method comprises (a) contacting a compound of formula (II) sequentially with a chiral base in the presence of an amine, and an alkylating agent R3-LG, (b) contacting the product of (a) with an acid to form a salt, and (c) reacting the salt with a base to form the compound of formula (I), wherein Z, R1, R2, and R3 are defined herein. | 2010-11-04 |
20100280256 | PROCESS FOR PREPARING TRIAZOLONES - The present process provides a improved method for the preparation of alkylsulfanyl substituted triazoles 2 which are useful intermediates in a new process for the preparation of triazolones 20. | 2010-11-04 |
20100280257 | PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS - The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II): | 2010-11-04 |
20100280258 | METHODS FOR THE PREPARATION OF AMPHILLIC NITROGEN CONTAINING IMIDAZOLINIUM DERIVATIVE COMPOUNDS - The disclosure provides new methods for preparing nitrogen-containing amphiphiles and their use in the preparation of liposomes and other lipid-containing carriers of pharmaceutical substances, including nucleic acids used in gene therapy. | 2010-11-04 |
20100280259 | N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof - N-tert-butoxycarbonyl-2-pyrrolidinones represented by the following formula (1). | 2010-11-04 |
20100280260 | Holographic storage medium comprising polyfunctional epoxy monomers capable of undergoing cationic polymerization - Disclosed is a holographic recording medium. The novel holographic recording mediums disclosed herein comprises: a) at least one polyfunctional epoxide monomer or oligomer which undergoes acid initiated cationic polymerization. Each epoxide in the monomer or oligomer is linked by group comprising a siloxane to a silicon atom and each monomer or oligomer has an epoxy equivalent weight of greater than about 300 grams/mole epoxide; b) a binder which is capable of supporting cationic polymerization; c) an acid generator capable of producing an acid upon exposure to actinic radiation; and optionally d) a sensitizer. | 2010-11-04 |
20100280261 | POROUS BODY PRECURSORS, SHAPED POROUS BODIES, PROCESSES FOR MAKING THEM, AND END-USE PRODUCTS BASED UPON THE SAME - The present invention provides porous body precursors and shaped porous bodies. Also included are catalysts and other end-use products based upon the shaped porous bodies and thus the porous body precursors. Finally, processes for making these are provided. The porous body precursors are germanium doped and comprise a precursor alumina blend. It has now surprisingly been discovered that inclusion of germanium, alone or in combination with such a blend, in porous body precursors can provide control over, or improvements to, surface morphology, physical properties, and/or surface chemistry of shaped porous bodies based thereupon. Surprisingly and advantageously, heat treating the shaped porous bodies can result in additional morphological changes so that additional fine tuning of the shaped porous bodies is possible in subsequent steps. | 2010-11-04 |
20100280262 | BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES - Biologically active compounds related to the bryostatin family of compounds, having simplified spacer domains and/or improved recognition domains are disclosed, including methods of preparing and utilizing the same. | 2010-11-04 |
20100280263 | Process for the Synthesis of Anticancer (Poly) Aminoalkylaminoacetamide Derivatives of Epipodophyllotoxin - The present invention describes a new process for the preparation of (poly)aminoalkylaminoacetamide compounds of epipodophyllotoxin useful for their applications in therapeutics as anticancer agents. This process comprises a step of condensation of a primary-amine-containing reactant, whose amine functions are not protected, with β-chloroacetamido-4′-epipodophyllotoxin in a polar aprotic organic solvent. | 2010-11-04 |
20100280264 | PRODUCTION OF ORGANIC SOLVENT SOLUTIONS OF RARE-EARTH ORGANOPHOSPHATES - Solutions of rare-earth organophosphates in an organic solvent are prepared by reacting, in such solvent, a rare-earth compound selected from among the rare-earth oxides, hydroxides, carbonates and hydroxycarbonates with an organophosphorus acid and in the presence of a reaction promoter selected from among water, nitric, hydrochloric, acetic, formic and propionic acids and the rare-earth salts of these acids; utilizing a reaction promoter simplifies the method, reduces the reaction time and provides a solution in which the residual solids content may be low. | 2010-11-04 |
20100280265 | CATALYST COMPOSITION INCLUDING ZIRCONIUM COMPOUNDS FOR ESTERFICATION REACTION AND METHOD FOR PREPARING ESTER COMPOUNDS - The present invention relates to an esterification catalyst composition that includes a zirconium compound and a method for producing an ester compound, which includes the steps of esterifying alcohol and carboxylic acid compounds by using the same, and it may be applied to a mass synthesis process. | 2010-11-04 |
20100280266 | Fixed-Bed Hydrosilylation Catalyst Complexes and Related Methods - The invention includes a fixed-bed catalyst complex that includes (i) a metal carbene catalyst, wherein the metal is platinum, and (ii) a catalyst support that includes one or more of silica, alumina and/or glass. The invention provides a fixed-bed catalyst complex that includes a catalyst complex including a carbene chosen from those represented by at least one of Formulae (I), (II), (III), and (IV): | 2010-11-04 |
20100280267 | METHOD FOR PRODUCING CYCLOPROPANE CARBOXYLIC ACID COMPOUND AND INTERMEDIATE THEREFOR - A method for producing a cyclopropanecarboxylic acid compound represented by formula (VI) | 2010-11-04 |
20100280268 | HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM - The present invention concerns a fluorescence resonance energy transfer based high throughput test system to measure the formation of the HIV gp41 six-helix bundle. In a first embodiment the current invention relates to a homogeneous time resolved fluorescence-based test system comprising a first helical polypeptide consisting essentially of the sequence of IQN36 (SEQ ID NO:1); a second helical polypeptide consisting essentially of the sequence of C34 (SEQ ID NO: 2) wherein said IQN36 is labeled with a light emitting fluorophore and said C34 is labeled with an ultra-violet excitable fluorophore. | 2010-11-04 |
20100280269 | METHOD FOR PRODUCTION OF ACRYLIC ACID - To provide a method of producing acrylic acid which enables low energy-consumption production of acrylic acid from glycerin mixtures including glycerin and one or more compound selected from the group consisting of fatty acids, fatty acid salts, glycerides, fatty acid esters, alkali compounds and alkali compound salts. The method of producing acrylic acid according to the present invention includes the steps of obtaining an acrolein mixture by causing a dehydration reaction to a glycerin mixture; and obtaining an acrylic acid mixture by causing an oxidation reaction to the acrolein mixture; and recovering acrylic acid from the acrylic acid mixture. | 2010-11-04 |
20100280270 | Process for the Prepartion of Iosimenol - A process for the preparation of iosimenol comprising reacting 5,5′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide] (C-VI) with a 3-halo-1,2-propanediol in an aqueous solvent. A process for the preparation of C-VI comprising reacting 3,3′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride] (C-V) with 3-amino-1,2-propanediol in the presence of an inorganic base and a suitable non-aqueous polar solvent. A process for the preparation of C-V comprising reacting 3-amino-5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride (C-IV) with malonyl dichloride in a solvent comprising a suitable ester solvent, a suitable nitrile solvent or mixtures thereof. | 2010-11-04 |
20100280271 | PROCESS FOR THE PREPARATION OF AROMATIC AMINES - Nitroaromatic compounds are hydrogenated in the gas phase to form aromatic amines with hydrogen in the presence of one or more catalysts arranged in stationary or virtually stationary beds in a reactor. In this process, the catalyst in the reactor is at least partly replaced continuously or at periodic intervals. At least 10% of the catalyst is replaced within each 20 day interval subsequent to start up of the reaction. | 2010-11-04 |
20100280272 | METHOD FOR OBTAINING AN AMINOINDAN MESYLATE DERIVATIVE - The invention relates to processes for preparing rasagiline mesylate that avoid the use of alcohol solvents, thereby producing rasagiline mesylate free of any alkyl mesylates, including isopropyl mesylate. The invention further relates to processes for purifying rasagiline mesylate to obtain a product free of alkyl mesylates, and to the thus obtained rasagiline mesylate. | 2010-11-04 |
20100280273 | HYDROGENATION OF ESTERS WITH RU/BIDENTATE LIGANDS COMPLEXES - The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of Ru complexes with bidentate ligands, having one amino or imino coordinating group and one phosphino coordinating group, in hydrogenation processes for the reduction of esters or lactones into the corresponding alcohol or diol respectively. | 2010-11-04 |
20100280274 | CATALYST ADDITIVES - A nickel slurry comprising a nickel catalyst, water and at least one rheology modifier, the activity of the nickel catalyst being equal to or greater than the activity of the equivalent nickel catalyst contained in a slurry which does not comprise rheology modifiers, wherein the at least one rheology modifier provides high viscosity at low shear stress and low viscosity at high shear stress. | 2010-11-04 |
20100280275 | METHODS AND SYSTEMS FOR GENERATING POLYOLS - Disclosed are methods for generating propylene glycol, ethylene glycol and other polyols, diols, ketones, aldehydes, carboxylic acids and alcohols from biomass using hydrogen produced from the biomass. The methods involve reacting a portion of an aqueous stream of a biomass feedstock solution over a catalyst under aqueous phase reforming conditions to produce hydrogen, and then reacting the hydrogen and the aqueous feedstock solution over a catalyst to produce propylene glycol, ethylene glycal and the other polyols, diols, ketones, aldehydes, carboxylic acids and alcohols. The disclosed methods can be run at lower temperatures and pressures, and allows for the production of oxygenated hydrocarbons without the need for hydrogen from an external source. | 2010-11-04 |
20100280276 | PROCESS FOR PREPARING 2-HYDROXYACETALS AND THE CORRESPONDING 2-HYDROXYALKANALS - What is described is a process for preparing 2-hydroxyacetals of the general formula in which R | 2010-11-04 |
20100280277 | PROCESS FOR MAKING ETHERS FROM ALKOXIDE ANIONS OR PRECURSORS OF ALKOXIDE ANIONS - Improved methods for making ethers. In particular, an alkoxide can be more effectively converted into an ether by reaction with a hydrocarbyl halide in the presence of a substantial excess of a hygroscopic base such as NaOH. When present in such an unconventional excess, the base serves multiple functions. As a consequence, the alkoxide is extensively converted to the desired ether rapidly at excellent yields. The reaction environment also aids later product isolation. The use of the NaOH rather than Na metal allows the ether product to be separated from water soluble impurities such as salt products, left over base, left over hydrocarbyl halide, formates, etc. by liquid-liquid extraction among aqueous and organic phases. | 2010-11-04 |
20100280278 | PROCESS FOR THE ALKOXYLATION OF ALCOHOLS - Processes for the alkoxylation of alcohols using alkylene epoxides in the presence of boron based catalysts are provided. | 2010-11-04 |
20100280279 | ALKYL ALKOXYLATES CONTAINING UNIQUE END GROUPS - Described is a process for the alkoxylation of alcohols with I, Cl, or CH | 2010-11-04 |
20100280280 | FLUOROALKYLALKOXYLATES - A fluorinated alkylalkoxylate, and a process for its preparation in which at least one fluorinated alcohol is contacted with at least one alkylene epoxide in the presence of a catalyst system comprising an alkali metal borohydride, and an organic quaternary salt. | 2010-11-04 |
20100280281 | ALKOXYLATION OF FLUORINATED ALCOHOLS - A fluorinated alkylalkoxylate, and a process for its preparation in which at least one fluorinated alcohol is contacted with at least one alkylene epoxide in the presence of a catalyst system comprising an alkali metal borohydride, and an organic quaternary salt. | 2010-11-04 |
20100280282 | PHOSPHATIDYL OLIGOGLYCEROLS - In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A) | 2010-11-04 |
20100280283 | Distillation Method for the Purification of Sevoflurane and the Maintenance of Certain Equipment that May be Used in the Distillation Process - Processes for preparing commercial quantities of a stable, pharmaceutically acceptable sevoflurane substantially free of impurities are claimed. In another embodiment, a process for removing reactive metal salts from the surface of metallic equipment used in the distillation of sevoflurane and rendering a non-inert metallic surface of the metallic equipment inert. | 2010-11-04 |
20100280284 | OPTICALLY ACTIVE 2,2'-BIPHENOL DERIVATIVE AND PRODUCTION METHOD OF SAME - An optically active 2,2′-biphenol derivative and a production method that enables simple and efficient production of this compound. More specifically, an optically active biphenol derivative represented by the following formulas (1) and (2), a method for optically resolving a biphenol derivative represented by formula (2′), a production method of an optically active biphenol derivative (1) comprising a step for reacting a Brønsted acid with a biphenol derivative (2), and a production method of an optically active biphenol derivative (3) comprising a step for reacting a Lewis acid with an optically active biphenol derivative (1) or an optically active biphenol derivative (2). In the following formulas, R represents, for example, a primary or secondary alkyl group having 1 to 10 carbon atoms, * represents an axially asymmetric center, X represents a halogen atom, and R | 2010-11-04 |
20100280285 | Treatment of Phenol - A process for the removal of by-products from a phenolic mixture, which process may include the following steps: subjecting a phenolic mixture to extractive distillation to produce an initial phenolic mixture, contacting the initial phenolic mixture containing phenol and one or more by products with a catalyst to produce a first purified phenol product mixture, and distilling the first purified phenol product mixture to produce a second purified phenol product mixture; wherein the extractive distillation is carried out in two columns, a higher pressure column and a lower pressure column. | 2010-11-04 |
20100280286 | Process For The Preparation of Beta and Alpha Cryptoxanthin - The present invention relates to a process for converting lutein and/or lutein esters to (3R)-β-cryptoxanthin and (3R,6′R)-α-cryptoxanthin, suitable for human consumption as dietary supplements, by employing safe and environmentally friendly reagents. (3R)-β-Cryptoxanthin and (3R,6′R)-α-cryptoxanthin are two rare food carotenoids that are not commercially available and the former exhibits vitamin A activity. In the first synthetic step, commercially available lutein and/or lutein esters are transformed into a mixture of dehydration products of lutein (anhydroluteins) in the presence of a catalytic amount of an acid. The resulting anhydroluteins are then converted to (3R)-β-cryptoxanthin (major product) and (3R,6′R)-α-cryptoxanthin (minor product) by heterogeneous catalytic hydrogenation employing transition elements of group VIII (Pt, Pd, Rh supported on alumina or carbon) in a variety of organic solvents under atmospheric pressure of hydrogen and at temperatures ranging from −15° C. to 40° C. Among these catalysts, Pt supported on alumina at 40° C. in ethyl acetate provides the best yield of (3R)-β-cryptoxanthin and (3R,6′R)-α-cryptoxanthin. Several homogeneous catalysts can also promote the regioselective hydrogenation of anhydroluteins to a mixture of (3R)-β-cryptoxanthin and (3R,6′R)-α-cryptoxanthin in low to moderate yields. The catalysts may be transition metal complexes such as palladium acetylacetonate, Rh(Ph | 2010-11-04 |
20100280287 | COBALT-MOLYBDENUM SULFIDE CATALYST MATERIALS AND METHODS FOR STABLE ALCOHOL PRODUCTION FROM SYNGAS - The present invention provides methods and compositions for the chemical conversion of syngas to alcohols. The invention includes catalyst compositions, methods of making the catalysts, and methods of using the catalysts including techniques to maintain catalyst stability. Certain embodiments teach compositions for catalyzing the conversion of syngas into products comprising at least one C | 2010-11-04 |
20100280288 | METHOD FOR RECOVERING A NATURAL GAS CONTAMINATED WITH HIGH LEVELS OF CO2 - The present invention provides a method for recovering a natural gas contaminated with high levels of carbon dioxide. A gas containing methane and carbon dioxide is extracted from a reservoir containing natural gas, where carbon dioxide comprises greater than 40 vol. % of the extracted gas. The extracted gas is scrubbed with a wash effective to produce a washed extracted gas containing less carbon dioxide than the extracted gas and at least 20 vol. % carbon dioxide. The washed extracted gas is oxidized with an oxygen containing gas in the presence of a partial oxidation catalyst to produce an oxidation product gas containing hydrogen, carbon monoxide, and carbon dioxide. The oxidation product gas is then utilized to produce a liquid methanol product. | 2010-11-04 |
20100280289 | Process for the Selective Oxidation of Methane - The present invention is a process for converting methane to methanol, comprising: feeding methane and gaseous air or oxygen or gaseous air enriched with oxygen to a reactor under an elevated pressure; | 2010-11-04 |
20100280290 | "METHOD OF MAKING M41S FAMILY MOLECULAR SIEVE" - This disclosure relates to a novel method of making and recovering M41S family molecular sieve materials using synthesis mixtures having high solids-content and without a purification step. The solids-content, for example, is in a range from about 20 wt. % to 50 wt. %. The method also includes the step of mixing at least a portion of the M41S made with another material to form a composition, wherein the amount of said material to be mixed with said M41S product is such that said composition having less than 10 wt. % free fluid. The material mixed with the M41S made includes metal oxides, metal nitrides, metal carbides and mixtures thereof, as well as absorptive material capable of absorbing mother liquor and selected from the group consisting of carbon silica, alumina, titania, zirconia and mixtures thereof. The amount of the wastewater generated by this novel method is reduced by at least 50% to as much as 100% as comparing with conventional method of making M41S materials. By reducing and/or eliminating at least a portion of the wastewater generated in the synthesis product, the new method reduces cost of making of M41S materials and provides a more environmentally-friendly synthesis product. | 2010-11-04 |
20100280291 | Process for the synthesis of perfluorobutadiene - Process for preparing perfluoro-1,3-butadiene, comprising the following steps:
| 2010-11-04 |
20100280292 | METHOD OF RECOVERING HYDROFLUORIC ACID - The present invention relates to a process for producing pentafluoroethane. More particularly, the subject of the invention is a continuous process for producing pentafluoroethane comprising (i) a step of fluorinating perchloroethylene (PER) with hydrofluoric acid, in the gas phase, in the presence of a catalyst, (ii) a step of separating the products issuing from step (i) in order to give a fraction of light products and a fraction of heavy products, comprising hydrofluoric acid, unreacted perchloroethylene and under-fluorinated products, and (iii) a step of pretreating the fraction of heavy products before recycling to step (i). | 2010-11-04 |
20100280293 | Method and apparatus for hydrogenating hydrocarbon fuels - In the present invention, there is provided a process and an apparatus for hydrogenating hydrocarbon fuels. A receptacle is partly filled an aqueous solution containing sodium hydroxide. A hydrocarbon fuel is then introduced inside the receptacle atop the aqueous solution. Aluminum is introduced in the aqueous solution, thereby producing hydrogen gas. The hydrogen gas is bubbled through the hydrocarbon fuel for hydrogenating the fuel. | 2010-11-04 |
20100280294 | CATALYST FOR THE HYDROGENATION OF UNSATURATED HYDROCARBONS AND PROCESS FOR ITS PREPARATION - The present invention relates to a catalyst for the hydrogenation of unsaturated hydrocarbons, in particular aromatics with a broad molecular weight range, a process for the production thereof and a process for hydrogenating unsaturated hydrocarbons. | 2010-11-04 |
20100280295 | USE OF A MIXTURE OF AN ORDERED INTERMETALLIC COMPOUND AND AN INERT MATERIAL AS A CATALYST AND CORRESPONDING HYDROGENATION PROCESSES - The present invention relates to a process for the hydrogenation, in particular selective hydrogenation of at least one unsaturated hydrocarbon compound comprising reacting the at least one unsaturated hydrocarbon compound with hydrogen in the presence of a hydrogenation catalyst, wherein the hydrogenation catalyst comprises a mixture of an ordered intermetallic compound and an inert material. According to another aspect, the present invention is concerned with the use of a mixture of at least one ordered intermetallic compound and at least one inert material, as a catalyst. The mixtures for use as a catalyst in the present invention can be prepared easily and achieve a superior activity in relation to the prior art, while preserving the high selectivity to the target compounds, e.g. in the selective hydrogenation of acetylene to ethylene. | 2010-11-04 |
20100280296 | PROCESS FOR SYNTHESIZING CUBIC METALLIC NANOPARTICLES IN THE PRESENCE OF TWO REDUCING AGENTS - A process is described for preparing cubic metallic nanoparticles, comprising:
| 2010-11-04 |
20100280297 | Process of using germanium zeolite catalyst for alkane aromatization - This invention is for a catalyst for conversion of alkanes having two to six carbon atoms per molecule to aromatics. The catalyst is a MFI zeolite with a crystallite size of less than 15 microns with, in addition to silicon and aluminum, germanium as a framework element. Platinum is deposited on the zeolite. The zeolite may contain other optional tetravalent and trivalent elements in the zeolite framework. The catalyst is synthesized by preparing a zeolite containing aluminum, silicon, germanium and, optionally, other elements in the framework, calcining the zeolite and depositing platinum on the zeolite. The catalyst may be used for aromatization of alkanes, such as propane, to aromatics, such as benzene, toluene and xylenes. | 2010-11-04 |
20100280298 | Liquid Phase Alkylation Process - The present invention provides an improved process for conversion of feedstock comprising an alkylatable aromatic compound and an alkylating agent to desired alkylaromatic conversion product under at least partial liquid phase conversion conditions in the presence of specific catalyst comprising a porous crystalline material, e.g., a crystalline aluminosilicate, and binder in the ratio of crystal/binder of from about 20/80 to about 60/40. The porous crystalline material of the catalyst may comprise a crystalline molecular sieve having the structure of Beta, an MCM-22 family material, e.g., MCM-49, or a mixture thereof | 2010-11-04 |
20100280299 | METHOD FOR THE PRODUCTION OF ALPHA, OMEGA-OLEFINS BY USING THE COPPER CATALYZED COUPLING REACTION OF A GRIGNARD REAGENT WITH AN ALLYLIC SUBSTRATE - A process for the synthesis of linear α,ω-diolefins from an allylic substrate comprises the steps of a) forming the bis-Grignard reagent XMgCH | 2010-11-04 |
20100280300 | MIXED MANGANESE FERRITE CATALYSTS, METHOD OF PREPARING THEREOF AND METHOD OF PREPARING 1,3-BUTADIENE USING THEREOF - A method of producing a mixed manganese ferrite catalyst, and a method of preparing 1,3-butadiene using the mixed manganese ferrite catalyst. Specifically, a method of producing a mixed manganese ferrite catalyst through a coprecipitation method which is performed at a temperature of 10˜40° C., and a method of preparing 1,3-butadiene using the mixed manganese ferrite catalyst through an oxidative dehydrogenation reaction, in which a C4 mixture containing n-butene, n-butane and other impurities is directly used as reactants without performing additional n-butane separation process or n-butene extraction. 1,3-butadiene can be prepared directly using a C4 mixture including n-butane at a high concentration as a reactant through an oxidative hydrogenation reaction without performing an additional n-butane separation process, and 1,3-butadiene, having high activity, can be also obtained in high yield for a long period of time. | 2010-11-04 |
20100280301 | PROCESS FOR REDUCING THE OXYGEN CONTENT OF HIGH-OXYGEN FEEDSTOCKS - A process is disclosed for reducing the oxygen content of a high-oxygen feedstock. The process is particularly suitable for biomass-based feedstocks. The process comprises contacting the feedstock with carbon monoxide and/or coke in the presence of a catalyst. Conveniently, the coke may be present in the form of a deposit on the catalyst. Carbon monoxide may be generated in a regeneration step of the catalyst. | 2010-11-04 |
20100280302 | CONTAINER FOR VIAL OF RADIOPHARMACEUTICAL AND SET FOR ITS INFUSION IN A PATIENT OR FOR ITS TRANSFER ELSEWHERE - A container for a vial of radiopharmaceutical, made of polymethyl methacrylate consists of a receptacle, with a cavity capable of containing the vial of radiopharmaceutical, and of a lid screwed onto the receptacle for closing the container, said lid presenting a central through-hole. A set, in combination with this container with the vial of radiopharmaceutical, consisting of a bottle of saline solution and two infusion catheters, enhances the radioprotection during the infusion of a radiopharmaceutical in an infusion operation. | 2010-11-04 |
20100280303 | DEVICES AND METHODS FOR TREATING MAGNETIC POISONING AND/OR MAGNETICALLY INDUCED ROULEAUX - A medical device including a Rouleaux degausser that directs a degaussing magnetic field to a patient's blood flow. The degaussing magnetic field reduces magnetically-induced Rouleaux and/or Red Blood Cell aggregation. The device also has a power source for supplying power to the Rouleaux degausser. | 2010-11-04 |
20100280304 | Magnetic Gastric Reduction Device - A magnetic gastric reduction device includes magnetic elements adapted to couple to a stomach and a sensor adapted to detect stomach properties. The device also includes a control device operably coupled to the magnetic elements. The control device is adapted to operably communicate with the sensor and is configured to control the magnetic elements based on a property of the stomach detected by the sensor to cause the magnetic elements to selectively compress or decompress the stomach. | 2010-11-04 |
20100280305 | BLOOD PUMP AND PUMP UNIT - Provided are a magnetic coupling as an axial bearing including a driven magnet ( | 2010-11-04 |
20100280306 | METHODS, DEVICES AND SYSTEMS FOR COUNTERPULSATION OF BLOOD FLOW TO AND FROM THE CIRCULATORY SYSTEM - Counterpulsation methods and systems for assisting the heart of a patient involve, for example, coordinating the operation of a pulsatile pump to suction blood from an artery through a first conduit while the heart is in systole and expel the blood into the first conduit and the artery while the heart is in diastole. | 2010-11-04 |
20100280307 | USING A GENETIC ALGORITHM IN MIXED MODE DEVICE - Apparatus and method for at least partially fitting a medical implant system to a recipient is described. The medical implant system is configured to provide electrical stimulation and at least one other mode of stimulation to the recipient. These apparatuses and methods comprise executing a genetic algorithm to select a set of parameter values for the medical implant system. This genetic algorithm may comprise generating successive generations of child populations and then providing a determined set of parameter values to the medical implant system for use in providing stimulation to the recipient. | 2010-11-04 |
20100280309 | ENDOSCOPIC MESH DELIVERY SYSTEM WITH INTEGRAL MESH STABILIZER AND VAGINAL PROBE - A mesh delivery system ( | 2010-11-04 |
20100280310 | Laparoscopic Gastric Band With Active Agents - A gastric banding system is provided which generally includes a gastric band and an active agent, for example, a metabolic agent or satiety inducing agent. The band may be structured to contain the agent and permit controlled release of the agent to the patient while the band is positioned around the stomach. Methods for treating obesity are also provided which include positioning a gastric band on the stomach of a patient and administering a satiety inducing agent to the patient while the gastric band is positioned on the stomach. | 2010-11-04 |
20100280311 | Adaptor for an Endoscope - An adaptor and a kit including an adaptor are provided. The adaptor is configured to connect an elongate medical device to an endoscope. The adaptor includes a first portion having a distal end sized and shaped to connect to an endoscope. The first portion includes a first opening defined therethrough. The adaptor further includes a second portion connectable to the first portion and including a second opening defined through the second portion and operably connectable to the first lumen. The second portion includes a connector at a proximal end portion sized and shaped to receive at least a portion of the elongate medical device so that a shaft of the elongate medical device is extendable distally through the first opening and the second opening and into the endoscope when the elongate medical device is connected to the adaptor. | 2010-11-04 |
20100280312 | Self-Contained Medical Applicators for Surgical Sealants, and Methods of Use Thereof - Aspects of the invention relate to an applicator, and methods of use thereof, which can house multiple component formulations in separate material receptacles, which components can then be easily combined at the time of use without assembly by the user. In certain embodiments, a device of the invention can be used for, but is not limited to, applying hydrogel formulations to dura mater, abdominal tissue in hernia repair, tissues near the spine, lung tissue, intestinal tissue, or any of the internal tissues. In certain embodiments, a device of the invention can be configured to apply a spray or a stream of a liquid formulation to a surface. In certain embodiments, a device of the invention can be configured to deliver the formulation through an endoscope or laparoscope. | 2010-11-04 |
20100280313 | SYSTEMS AND METHODS FOR ENDOSCOPIC INVERSION AND REMOVAL OF DIVERTICULA - Systems and methods are disclosed for the inversion of gastro intestinal diverticula and repair of associated intestinal wall tissue by means of endoscopy through a natural orifice such as the mouth or anus without making incisions in the abdominal wall or opening the peritoneal cavity. | 2010-11-04 |
20100280314 | UROLOGICAL RESECTOSCOPE COMPRISING HOLES - A resectoscope comprising a shaft that has an external tube and an internal tube. A lens system which has an angular field of view and can be rotated relative to the external tube along with the internal tube is disposed inside the internal tube. The distal end region of the internal tube is designed to slide in a sealed manner along the external tube. The external tube has holes in the distal end region proximal to the end region of the internal tube. The interior of the internal tube is connected as a supply duct while the intermediate space between the tubes is connected as a discharge duct. The disclosed resectoscope is characterized in that the holes are distributed along the circumference, while the internal tube is fitted with a covering device which covers the holes in a circumferential zone. | 2010-11-04 |
20100280315 | OPTICAL COHERENCE TOMOGRAPHY SYSTEMS AND METHODS - In general, in one aspect, the invention features a method that includes using an optical coherence tomography system to acquire a plurality of frames of a sample where each frame includes optical information about the composition of the sample through a section of the sample. The method further includes averaging over two or more of the frames to provide an image of the section of the sample where successive frames of the two or more frames are acquired with a time lapse of 0.05-0.7 seconds. Embodiments of the method may have unique advantages for endoscopic subcellular imaging. For example, they can enable subcellular imaging with low-NA optics (e.g., NA=0.25 or less) while providing morphological imaging of the underlying tissue up to 0.6 mm without focal tracking. | 2010-11-04 |
20100280316 | CATHETER - An improved catheter is provided. The catheter may include a deflectable member located at a distal end of a catheter body. The deflectable member may comprise an ultrasound transducer array. The deflectable member may be interconnected to the catheter body by a live hinge. The catheter may include a lumen extending from a proximal end of the catheter body to the distal end. The lumen may be used to deliver an interventional device to a point distal to the distal end of the catheter body. The deflectable member may be selectively deflectable in a pivot-like manner through an arc of at least 90 degrees. In embodiments where the deflectable member includes an ultrasound transducer array, the ultrasound transducer array may be operable to image both when aligned with the catheter body and when pivoted relative to the catheter body. | 2010-11-04 |
20100280317 | OCULAR IMPLANT DELIVERY SYSTEMS AND METHODS - Described herein are delivery devices and methods of using the devices for delivering an ocular implant into a suprachoroidal space without use of a goniolens. The delivery device includes a handle including a channel extending from a proximal end of the handle to a distal end of the handle, an applier coupled to the handle, the applier including a blunt distal tip and an elongate, flexible wire insertable through a fluid channel of an ocular implant, and a fiber optic image bundle reversibly inserted through the channel such that the fiber optic image bundle extends to a region proximal to the blunt distal tip of the applier. | 2010-11-04 |
20100280318 | Colonoscope Guide and Method of Use for Improved Colonoscopy - A guide and method for tilting a colonoscope in the rectum leftward toward the descending colon to advance the colonoscope through the colon during colonoscopy. The guide comprises a rigid elongated body member and a handle attached to or integral with the body member. The body member has an insertion length selected so as to not be inserted past the patient's rectum. The body member can be curved or tubular to better engage the colonoscope. A soft liner can be utilized to protect the endoscope during use. Preferably, the body member has a semi-circular cross-section with a flexible inner tubular member attached thereto that receives the endoscope. A longitudinal slot facilitates loading the endoscope into the tubular member. In another embodiment, the body member comprises upper and lower rigid body members connected by an engaging mechanism. The user tilts the colonoscope with the guide to minimize or avoid sigmoid looping. | 2010-11-04 |
20100280319 | ELASTOMER MOLDING FOR ENDOSCOPE - The invention provides a flexible tube for an endoscope, which is excellent in elasticity (impact resilience), has suitable flexibility and also has chemical resistance. Disclosed is a flexible tube for an endoscope including a flexible-tube material covered thereon with a jacket, wherein the jacket contains two or more thermoplastic polyester elastomers crosslinked therein. | 2010-11-04 |
20100280320 | FLEXIBLE AND STEERABLE ELONGATE INSTRUMENTS WITH SHAPE CONTROL AND SUPPORT ELEMENTS - An instrument having a flexible and elongated body includes at least a lumen and a flex member disposed within the lumen. The flex member may be capable of providing steering control to a first portion of the elongate body while providing load bearing support to a second portion of the elongate body. A pull wire may be disposed within the flex member, and at least a distal portion of the pull wire may be coupled to the elongate body and a proximal portion of the pull wire may be operatively coupled to a control unit. The control unit may be coupled to a proximal portion of the elongate body. In addition, a control member may be operatively coupled to the control unit such that a distal portion of the control member may be positioned near a proximal portion of the flex member. The control member may be configured to support the flex member and control the movement or displacement of the flex member. Furthermore, the flex member may be configured to selectively decouple articulation or steering forces of a first portion of the elongate body away from a second portion of the elongate body; thereby, preventing compression of the second portion of the elongate body while maintaining elasticity or flexibility of the second portion of the elongate body. | 2010-11-04 |
20100280321 | Self-interfering tomography system - Light is collected from a sample that is to be imaged, such as tissue or the like, and made to undergo self-interference, e.g., on a detector. An imaging system may include a low coherence light source arranged for illuminating the sample, and an interferometer arranged to receive the light collected from the sample and to pass it to a detector. The interferometer includes a beam divider that directs the radiation collected from the sample along two paths, phase-delaying one beam relative to another and then recombining the beams on a detector. A processor may be coordinated with the phase delay and in some embodiments with spatial scanning or detector array addresses, and operates on the signal from the detector to form a tomographic image of the sample illuminated tissue. By constructing an image based upon interference the interferometric signal from of the split and then recombined radiation collected from the sample signal, rather than interference of a source reference and a return signal, the invention is able to image with light naturally emitted by the sample. , or with wavelength-shifted, delayed or induced light signals of different types, allowing new modalities of diagnostic and other imaging of the sample and its structure. A processor generates one or more images of the structure being viewed, and may create images in registry from different (for example, close but separable) wavelengths. Some systems may operate without an illumination source or may apply other stimuli to evoke emission from the sample. | 2010-11-04 |
20100280322 | ILLUMINATION DEVICE FOR USE IN ENDOSCOPE - An illumination device for use in an endoscope includes a light source, an optical fiber and a wavelength conversion member. The optical fiber guides light to a tip end of an endoscope insertion portion of the endoscope. The wavelength conversion member is provided at an emission end of the optical fiber. The wavelength conversion member configured to be excited by the light source. The illumination device can provide white illumination light obtained by mixing light emitted from the optical fiber and light obtained by exciting the wavelength conversion member by the light emitted from the optical fiber. Also, the illumination device can provide illumination light being different from the white illumination light, by using other excitation light. | 2010-11-04 |
20100280323 | Ceramic Fiber Optic Taper Housing For Medical Devices - A system for transmitting the light required for a medical device is disclosed generally comprising an endoscope body, a light guide for transmitting light from a light source to the instrument body, where the light guide includes a bundle of optical fibers having a tapered portion, and a ceramic housing disposed around at least part of the tapered portion of the bundle. In certain embodiments, the ceramic has a pigment for improving insulation. In some embodiments, the taper and ceramic housing are located in an endoscope handle, which may be coupled to the endoscope body via an input post, and in certain embodiments, the inner diameter of the ceramic housing has an increase substantially equal to the decrease of diameter of the taper. | 2010-11-04 |
20100280324 | Organ Manipulator Having Suction Member Supported with Freedom to Move Relative to Its Support - An organ manipulator including at least one suction member or adhesive disk mounted to a joint providing freedom of movement of the at least one suction member or adhesive disk relative to its support. A method for retracting and maintaining an organ in a retracted position using suction (or adhesive force) so that the organ is free to move normally (e.g., to beat or undergo other limited-amplitude motion) is provided. | 2010-11-04 |
20100280325 | RETRACTORS AND SURGICAL SYSTEMS INCLUDING THE SAME - Retractors and surgical systems that include retractors are disclosed. | 2010-11-04 |
20100280326 | SURGICAL DEVICES FOR INTERNAL ACCESS THROUGH TISSUE - Methods and devices are provided for providing access through tissue to a surgical site. In one embodiment, a surgical access device can be configured to move between a first, expanded configuration, and a second, compressed configuration. As the device moves from the first configuration to the second configuration, a longitudinal length of the device can decrease, thereby allowing the device to be securely positioned in tissue and reducing a distance that the device extends into a body cavity. | 2010-11-04 |
20100280327 | METHODS AND DEVICES FOR PROVIDING ACCESS THROUGH TISSUE TO A SURGICAL SITE - Methods and devices are provided for providing access through tissue to a surgical site. In one embodiment, a surgical access device can be configured to move between a first, expanded configuration, and a second, compressed configuration. As the device moves from the first configuration to the second configuration, a longitudinal length of the device can decrease, thereby allowing the device to be securely positioned in tissue and reducing a distance that the device extends into a body cavity. | 2010-11-04 |
20100280328 | METHODS AND SYSTEMS FOR ILLUMINATION DURING PHLEBECTOMY PROCEDURES - A method comprising (a) illuminating a blood vessel in a relatively low-light surgical field by inserting a subcutaneous light source into tissue near the blood vessel and to a first location in the tissue underlying the blood vessel, and causing emission of light from the subcutaneous light source while the subcutaneous light source is at the first location, so that light from the subcutaneous light source passes through the tissue near the blood vessel, toward an observer; (b) drawing a portion of the tissue near the blood vessel through an incision in the skin; and (c) illuminating the drawn portion of tissue by activating an external light source in a hands-free manner, thereby facilitating determining whether the drawn tissue is the blood vessel. | 2010-11-04 |
20100280329 | ESTIMATING A NUTRITIONAL PARAMETER FOR ASSISTING INSULIN ADMINISTRATION - A device for estimating a nutritional parameter of a meal consumed by an individual is disclosed. The apparatus comprises processing means adapted to obtain input values of at least a physiological parameter of the user measured prior to and after intake of a meal by the user, and of at least a dose of medication administered to the user. Based on the input values the apparitus is adapted to determine from at least the obtained input values, an estimate of a nutritional parameter of the meal and to generate an output to a user indicative of the determined estimate. | 2010-11-04 |
20100280330 | TRANSCEIVER UNIT IN A MEASUREMENT SYSTEM - A measurement system may comprise a sensor wire and a transceiver unit. The sensor wire may comprise an insertable portion configured to be inserted in a blood vessel of a patient's body and a sensor disposed within the insertable portion at a distal end of the sensor wire. The sensor is configured to measure a parameter when inserted inside the patient. The transceiver unit may comprise: a housing adapted to be connected to a proximal end of the sensor wire; and a first communication module within the housing adapted to wirelessly communicate by a communication signal with an external second communication module in order to transfer information to the external second communication module. | 2010-11-04 |
20100280331 | Method and apparatus for non-invasively estimating body core temperature - Non-invasive methods and devices are disclosed to derive estimates of body Core Temperature from external sensors that provide electrocardiograph (ECG) data, and Mean Skin Temperature data. The ECG and Mean Skin Temperature are input to a model that provides estimates of Core Temperature temperature. The model is derived regressively from ECG, Mean Skin Temperature and Core Temperature data obtained from a number of test subjects. A monitoring device may be used, for example, to trigger an alarm, display Core Temperature data to the device wearer or to a remote monitoring station, or to activate an emergency temperature control system or device. | 2010-11-04 |
20100280332 | Methods and systems for monitoring bioactive agent use - Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual. | 2010-11-04 |
20100280333 | Medical Vital Sign Indication Tool, System and Method - A vital sign evaluation tool ( | 2010-11-04 |
20100280334 | PATIENT STATE DETECTION BASED ON SUPPORT VECTOR MACHINE BASED ALGORITHM - A patient state is detected with at least one classification boundary generated by a supervised machine learning technique, such as a support vector machine. In some examples, the patient state detection is used to at least one of control the delivery of therapy to a patient, to generate a patient notification, to initiate data recording, or to evaluate a patient condition. In addition, an evaluation metric can be determined based on a feature vector, which is determined based on characteristics of a patient parameter signal, and the classification boundary. Example evaluation metrics can be based on a distance between at least one feature vector and the classification boundary and/or a trajectory of a plurality of feature vectors relative to the classification boundary over time. | 2010-11-04 |
20100280335 | PATIENT STATE DETECTION BASED ON SUPERVISED MACHINE LEARNING BASED ALGORITHM - A patient state is detected with at least one classification boundary generated by a supervised machine learning technique, such as a support vector machine. In some examples, the patient state detection is used to at least one of control the delivery of therapy to a patient, to generate a patient notification, to initiate data recording, or to evaluate a patient condition. In addition, an evaluation metric can be determined based on a feature vector, which is determined based on characteristics of a patient parameter signal, and the classification boundary. Example evaluation metrics can be based on a distance between at least one feature vector and the classification boundary and/or a trajectory of a plurality of feature vectors relative to the classification boundary over time. | 2010-11-04 |
20100280336 | ANXIETY DISORDER MONITORING - An anxiety episode may be identified as being an anxiety event that is attributable to an anxiety disorder of a patient based on the patient activity associated with the anxiety episode. The patient activity may include, for example, patient motion, patient posture or voice activity. Detection of the activity component during an anxiety episode can help distinguish between a general anxiety state and an anxiety event that differs from the general anxiety state. Examples of anxiety events include, for example, an occurrence of a compulsion or a panic attack. The detected anxiety events can be used to evaluate an anxiety disorder of a patient, evaluate therapy programs implemented by a medical device to treat the anxiety disorder, or control therapy delivery. In some examples, a mood state transition is detected based on patient activity information and therapy delivery is controlled based on the detection of the mood state transition. | 2010-11-04 |
20100280337 | SIMULTANEOUS AMBULATORY PULSE OXIMETRY AND PH MONITORING FOR THE DIAGNOSIS OF GERD-RELATED RESPIRATORY DISEASE - Respiratory diseases related to gastroesophageal reflux disease in a patient are diagnosed by detecting esophageal or pharyngeal impedance and pH in the patient, detecting oxygen saturation in the patient, and diagnosing the respiratory diseases from the esophageal or pharyngeal impedance, the pH, and the oxygen saturation. | 2010-11-04 |
20100280338 | EAR-WORN BIOFEEDBACK DEVICE - An ear-worn biofeedback device is provided including an ear-worn structure for mounting on at least an ear of the user, at least a housing attached to the ear-worn structure, at least a sensor/electrode, for acquiring biosignals, and a circuit system accommodated in the housing. The circuit system includes an analog/digital converter for receiving and digitizing biosignals acquired by the sensor/electrode, a processor, a battery, for providing power, and a sound module, disposed around the ear, wherein during the biofeedback process, the digitized biosignals are analyzed, and when a preset condition is matched, the processor notifies the user by driving the sound module to generate audio signals for being received by the ear. | 2010-11-04 |
20100280339 | AUTOMATIC WIRELESS PAN/LAN SWITCHING - A communication system is used by a portable patient monitoring device for connecting to other devices, including a docking station, via one or more networks. The communications system includes an adaptive communication interface which, when the patient monitoring device is docked, establishes communication with a first network, and receives from a first docking station a first unique identifier that identifies the first docking station, allowing the patient monitoring device to communicate patient parameters to the first destination. While the portable patient monitoring device is undocked, the adaptive communication interface is inhibited from establishing communication with a network providing an identifier to the portable patient monitor that does not match the first unique identifier. Upon docking to a second docking station, the patient monitoring device establishes communication with a second network using a new unique identifier received from the second docking station via a second exclusive communication link. | 2010-11-04 |
20100280340 | MEDICAL SYSTEM AND METHOD OF SWITCHING ANTENNA - A medical system includes a capsule type medical apparatus introduced into a subject and having an antenna having directionality and a communication unit which executes a communication through the antenna, an external antenna, which is disposed outside of the subject and has an antenna having directionality and an antenna disposed together with the antenna and having directionality in a direction different from the antenna, and an external machine having a selection unit which selects any of the antennas in the external antenna and a second communication unit which executes a communication with the first communication unit through the antenna whose polarized wave surface is selected by the selection unit. | 2010-11-04 |
20100280341 | POLYMER MEMBRANES FOR CONTINUOUS ANALYTE SENSORS - Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species. | 2010-11-04 |
20100280342 | MULTIPLE WAVELENGTH PHYSIOLOGICAL MEASURING APPARATUS, SENSOR AND INTERFACE UNIT FOR DETERMINATION OF BLOOD PARAMETERS - A measuring apparatus, a physiological sensor, and an interface unit for determining blood parameters of a subject are disclosed. The sensor comprises an emitter unit comprising a first plurality of emitter elements configured to emit radiation at a second plurality of wavelengths and a detector unit configured to receive radiation generated by the emitter elements and transmitted through the tissue of the subject, wherein the detector unit is further configured to produce electric measurement signals indicative of absorption caused by the blood of the subject. In order to make the sensor compatible with a variety of different monitoring units, the sensor or the interface unit is provided with a memory that stores emitter activation information for at least a third plurality of wavelengths, thereby to enable a monitoring unit operably connectable to the physiological sensor to employ a combination of wavelengths selected from the third plurality of wavelengths, wherein the third plurality is equal to or smaller than the second plurality. | 2010-11-04 |
20100280343 | MULTIPLE WAVELENGTH PHYSIOLOGICAL MEASURING APPARATUS, SENSOR AND INTERFACE UNIT FOR DETERMINATION OF BLOOD PARAMETERS - A measuring apparatus, a physiological sensor, and an interface unit for determining blood parameters of a subject are disclosed. The sensor comprises an emitter unit comprising a first plurality of emitter elements configured to emit radiation at a second plurality of wavelengths and a detector unit configured to receive radiation generated by the emitter unit and transmitted through tissue of the subject. The sensor further comprises a sensor memory storing sensor-specific information about the sensor unit, wherein the sensor-specific information includes at least calibration data for a given measurement mode, and a memory access interface for enabling an entity external to the sensor to update at least part of the sensor-specific information in a sensor ability update process, thereby to update ability of the sensor unit to operate in the given measurement mode. | 2010-11-04 |
20100280344 | MEDICAL SENSOR FOR REDUCING MOTION ARTIFACTS AND TECHNIQUE FOR USING THE SAME - A sensor may be adapted to reduce motion artifacts by damping the effects of outside forces and sensor motion. A sensor is provided with a motion damping structure adapted to reduce the effect of motion of a sensor emitter and/or detector. Further, a method of damping outside forces and sensor motion is also provided. | 2010-11-04 |
20100280345 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2010-11-04 |
20100280346 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2010-11-04 |